Back to Search
Start Over
Validation of Clinical Risk Models for Clostridioides difficile - Attributable Outcomes
- Source :
- Antimicrobial Agents and Chemotherapy. 66
- Publication Year :
- 2022
- Publisher :
- American Society for Microbiology, 2022.
-
Abstract
- Clostridioides difficile is the leading health care-associated pathogen, leading to substantial morbidity and mortality; however, there is no widely accepted model to predict C. difficile infection severity. Most currently available models perform poorly or were calibrated to predict outcomes that are not clinically relevant.
- Subjects :
- Pharmacology
Infectious Diseases
Pharmacology (medical)
Subjects
Details
- ISSN :
- 10986596 and 00664804
- Volume :
- 66
- Database :
- OpenAIRE
- Journal :
- Antimicrobial Agents and Chemotherapy
- Accession number :
- edsair.doi...........06ace523111ea15932886ca71e02fe8a